|
Senate Counsel, Research and Fiscal Analysis
|
Minnesota Senate Bldg.
|
95 University Avenue W. Suite 3300
|
St. Paul, MN 55155
|
(651) 296-4791
|
Alexis C. Stangl
|
Director
|
|
|
Senate
|
State of Minnesota
|
|
|
|
|
|
|
|
S.F. No. 2578 - Modifying the Schedules of Controlled Substances
|
|
Author:
|
Senator Paul T. Anderson
|
|
Prepared By:
|
Chris Turner, Senate Fiscal Analyst (651/296-4350)
|
|
Date:
|
March 2, 2018
|
|
|
|
|
Section 1 adds substances to Schedule I, which makes those substances illegal to sell or possess. The substances are:
-
Mitragynine and 7-hydroxymitragynine – the main active ingredients in a plant called kratom. These substances are considered opiates because they activate the same receptors in the brain that opiates, such as morphine and heroin, activate.
-
4-(4-bromophenyl)-4-dimethylamino-1-phenethylcyclohexanol (bromadol), which is a synthetic opiate that law enforcement agencies have seized during arrests. It is at least 500 times more potent than morphine, making the treatment of overdoses very difficult.
-
1-(3-chlorophenyl) piperazine (meta-chlorophenylpiperazine or mCPP), which is a synthetic stimulant that law enforcement agencies have also been seizing.
Section 2 aligns Schedule IV with the version of Schedule IV found in the board’s rule by adding the following opiate drugs:
-
Pentazocine.
-
butorphanol (including its optical isomers).
The additions to Schedule IV are simply to align Schedule IV in the rules and statutes. Since these drugs are already scheduled in rule, there will be no impact other than clearing up confusion caused by the different versions of the Schedules.
|
|
|
Check on the status of this bill
|
|
Back to Senate Counsel and Research Bill Summaries page
|
|
|
|
This page is maintained by the Office of Senate Counsel, Research, and Fiscal Analysis for the Minnesota Senate.
|
|
Last review or update: 03/02/2018
|
|
If you see any errors on this page, please e-mail us at
webmaster@senate.mn
|